These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12493341)

  • 1. Overview consensus statement.
    Staskin DR; Wein AJ; Andersson KE; Bauer SB; Blaivas JG; Burgio KL; Cardozo L; Chapple CR; Dmochowski RR; Gupta S; Mostwin JL; Ouslander JG; Weiss JP; King L
    Urology; 2002 Nov; 60(5 Suppl 1):1-6. PubMed ID: 12493341
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of overactive bladder.
    Ouslander JG
    N Engl J Med; 2004 Feb; 350(8):786-99. PubMed ID: 14973214
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of the overactive bladder with detrusitol].
    Golomb J
    Harefuah; 2000 Dec; 139(11-12):467-70. PubMed ID: 11341197
    [No Abstract]   [Full Text] [Related]  

  • 4. Tolterodine for overactive bladder.
    Med Lett Drugs Ther; 1998 Oct; 40(1038):101-2. PubMed ID: 9813595
    [No Abstract]   [Full Text] [Related]  

  • 5. [Bladder contraction. II. Biomechanical analysis of bladder contraction].
    Plante P
    J Urol (Paris); 1983; 89(7):461-82. PubMed ID: 6655277
    [No Abstract]   [Full Text] [Related]  

  • 6. Overactive bladder: an update.
    Hashim H; Abrams P
    Curr Opin Urol; 2007 Jul; 17(4):231-6. PubMed ID: 17558264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A UK consensus on the management of the bladder in multiple sclerosis.
    Fowler CJ; Panicker JN; Drake M; Harris C; Harrison SC; Kirby M; Lucas M; Macleod N; Mangnall J; North A; Porter B; Reid S; Russell N; Watkiss K; Wells M
    J Neurol Neurosurg Psychiatry; 2009 May; 80(5):470-7. PubMed ID: 19372287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimuscarinics for the treatment of overactive bladder: current options and emerging therapies.
    Hegde SS; Mammen M; Jasper JR
    Curr Opin Investig Drugs; 2004 Jan; 5(1):40-9. PubMed ID: 14983972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolterodine once-daily in treatment of the overactive bladder.
    Peters KM; Huang RR
    Urology; 2001 Nov; 58(5):829-32. PubMed ID: 11711378
    [No Abstract]   [Full Text] [Related]  

  • 10. The pharmacotherapy of overactive bladder.
    Athanasopoulos A
    Expert Opin Pharmacother; 2011 May; 12(7):1003-5. PubMed ID: 21291348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Female lower urinary tract symptoms: pharmacotherapeutic consequences.
    Blatvas JG
    BJU Int; 2000 Oct; 86 Suppl 2():1-9; discussion 9-10. PubMed ID: 11501612
    [No Abstract]   [Full Text] [Related]  

  • 12. Factors involved in the success of antimuscarinic treatment.
    Abrams P; Larsson G; Chapple C; Wein AJ
    BJU Int; 1999 Mar; 83 Suppl 2():42-7. PubMed ID: 10210604
    [No Abstract]   [Full Text] [Related]  

  • 13. [Conservative treatment of functional disorders of the lower urinary tract].
    Frohneberg D; Thüroff JW; Müller SC; Petri E
    Gynakologe; 1983 Dec; 16(4):206-13. PubMed ID: 6363223
    [No Abstract]   [Full Text] [Related]  

  • 14. The non-neurogenic neurogenic bladder.
    Allen TD
    J Urol; 1977 Feb; 117(2):232-8. PubMed ID: 833977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic perspective on the physiology of the lower urinary tract.
    Andersson KE; Hedlund P
    Urology; 2002 Nov; 60(5 Suppl 1):13-20; discussion 20-1. PubMed ID: 12493344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy and safety of tamsulosin in women with bladder outlet obstruction].
    Maksimov VA; Khodyreva LA; Dudareva AA; Aĭsina ÉF
    Urologiia; 2012; (5):115-6, 118-20. PubMed ID: 23342629
    [No Abstract]   [Full Text] [Related]  

  • 17. Detrol LA and Diropan XL for overactive bladder.
    Med Lett Drugs Ther; 2001 Apr; 43(1101):28. PubMed ID: 11283473
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug treatment of overactive bladder: efficacy, cost and quality-of-life considerations.
    Hashim H; Abrams P
    Drugs; 2004; 64(15):1643-56. PubMed ID: 15257626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bladder storage and voiding dysfunctions : Side effects of drug therapy].
    Wolfesberger J; Falkensammer CE; Madersbacher S
    Urologe A; 2017 Apr; 56(4):456-464. PubMed ID: 28233038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial.
    Chapple C
    Neurourol Urodyn; 2009; 28(5):367. PubMed ID: 19591127
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.